SARS-CoV-2 NSP9 antibody
Quick Overview for SARS-CoV-2 NSP9 antibody (ABIN7273002)
Target
See all SARS-CoV-2 NSP9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- anti-NSP9 (SARS-CoV-2)
-
Sequence
- MNNELSPVAL RQMSCAAGTT QTACTDDNAL AYYNTTKGGR FVLALLSDLQ DLKWARFPKS DGTGTIYTEL EPPCRFVTDT PKGPKVKYLY FIKGLNNLNR GMVLGSLAAT VRLQ
-
Specificity
- In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.
-
Cross-Reactivity (Details)
- Reacts with SARS-CoV-2 protein
-
Purification
- Epitope affinity purified
-
Immunogen
- Affinity purified recombinant fusion protein Nsp9 produced in E. coli.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:2,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 3 mg/mL
-
Buffer
- PBS, 20 % glycerol and 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- The antibody solution should be gently mixed before use.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- For continuous use, store at 2-8 C for one-two days. For extended storage, store in -20 C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- SARS-CoV-2 NSP9 (SARS-CoV-2 Non-Structural Protein 9 (SARS-CoV-2 NSP9))
-
Alternative Name
- NSP9 (SARS-CoV-2)
-
Target Type
- Viral Protein
-
Background
-
Nsp9 is part of the multifunctional protein replicase polyprotein 1ab that is involved in the transcription and replication of viral RNA. This non-structural protein, May participate in viral replication by acting as a ssRNA-binding protein.
Nsp9 SARS Coronavirus-2 antibody.
Target
-